NCT07259317 2026-02-20Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaCorcept TherapeuticsPhase 2 Recruiting60 enrolled
NCT01010945 2024-11-21Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerAstellas Pharma IncPhase 1 Completed19 enrolled
NCT02993731 2023-11-15CanStem111PSumitomo Pharma America, Inc.Phase 3 Completed1,134 enrolled 18 charts
NCT04299880 2023-11-08Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsSumitomo Pharma America, Inc.Phase 1 Completed7 enrolled
NCT02077881 2020-05-28Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerLumos PharmaPhase 1/2 Completed157 enrolled